Bom HC: LARR Authority Can Examine Limitation Issues in Land Acquisition References under 2013 Act  ||  MP HC: Long-Serving Employees Cannot Be Denied Regularisation by Retrospective Statutory Amendments  ||  J&K&L HC: Routine Challenges to Lok Adalat Awards Defeat Their Purpose of Quick Dispute Resolution  ||  Bombay HC: Restricting Compensation For Wild Animal Damage to Select Species Violates Article 14  ||  Supreme Court: Corporate Guarantee Constitutes as Financial Debt under the IBC  ||  Supreme Court: No Right to Full Tenure Exists When Appointment is Made ‘Until Further Orders’  ||  SC Mandates Trial Courts Seek Reports on Mitigating and Aggravating Factors Before Death Sentencing  ||  Supreme Court: Schools Cannot Delay Admission of State-Allotted Student over an Eligibility Dispute  ||  J&K&L HC: Delay in Executing Preventive Detention on Unsubstantiated Medical Ground Makes it Invalid  ||  Delhi HC Allows AITA Results For Interim Management and Directs Fresh Elections Under New Sports Law    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved